The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: -3.50 (-0.20%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WRAPUP 2-West Africa Ebola outbreak could infect 20,000 people, WHO says

Thu, 28th Aug 2014 17:19

* Number of cases possibly 2-4 times higher than reported

* 12,000 local staff, 750 international experts needed

* Nigeria reports spread to main African oil hub

* Air service suspension threatens aid operation - WHO (Adds details, quotes)

By Stephanie Nebehay and Tim Cocks

GENEVA/LAGOS, Aug 28 (Reuters) - The Ebola epidemic in WestAfrica could infect over 20,000 people and spread to morecountries, the U.N. health agency said on Thursday, warning thatan international effort costing almost half a billion dollars isneeded to overcome the outbreak.

The World Health Organisation (WHO) announced a $490 millionstrategic plan to contain the epidemic over the next ninemonths, saying it was based on a projection that the virus couldspread to 10 further countries beyond the four now affected -Guinea, Liberia, Sierra Leone and Nigeria.

With the IMF warning about the economic effects of theoutbreak, Nigeria reported that a doctor indirectly linked tothe Liberian-American who brought the disease to the country haddied of Ebola in Port Harcourt, Africa's largest energy hub.

In Britain, drugmaker GlaxoSmithKline said anexperimental Ebola vaccine is being fast-tracked into humanstudies and it plans to produce up to 10,000 doses for emergencydeployment if the results are good.

So far 3,069 cases have been reported in the outbreak butthe WHO said the actual number could already be two to fourtimes higher. "This is not a West African issue or an Africanissue. This is a global health security issue," WHO's AssistantDirector-General Dr Bruce Aylward told reporters in Geneva.

With a fatality rate of 52 percent, the death toll stood at1,552 as of Aug. 26. That is nearly as high as the total fromall recorded outbreaks since Ebola was discovered in what is nowDemocratic Republic of Congo in 1976.

The figures do not include deaths from a separate Ebolaoutbreak announced at the weekend in Congo, which has beenidentified as a different strain of the virus.

Aylward said tackling the epidemic would need thousands oflocal staff and 750 international experts. "It is a bigoperation. We are talking (about) well over 12,000 peopleoperating over multiple geographies and high-risk circumstances.It is an expensive operation," he said.

The operation marks a major raising of the response by theWHO, which had been accused by some aid agencies of reacting tooslowly to the outbreak.

Medical charity Medecins sans Frontieres (MSF) welcomed theWHO plan but said the important thing was now to act upon it.

"Huge questions remain about who will implement the elementsin the plan," said MSF operations director Brice de le Vingne."None of the organisations in the most-affected countries ...currently have the right set-up to respond on the scalenecessary to make a serious impact."

EXPERIMENTAL DRUGS

Early this month, the WHO classified the Ebola outbreak asan international health emergency. Concerns that the diseasecould spread beyond West Africa have led to the use of drugsstill under development for the treatment of a handful of cases.

Two American health workers, who contracted Ebola whiletreating patients in Liberia, received an experimental therapycalled ZMapp, a cocktail of antibodies made by tiny Californiabiotech Mapp Biopharmaceutical. They recovered and were releasedfrom hospital last week.

The virus has already killed an unprecedented number ofhealth workers and is still being spread in a many places, theWHO said. About 40 percent of the cases have occurred within thepast 21 days, its statistics showed.

Previous Ebola outbreaks have mainly occurred in isolatedareas of Central Africa. However the current epidemic has spreadto three West African capitals and Lagos, Africa's biggest city.The WHO said special attention would need to be given tostopping transmission in capital cities and major ports.

Authorities in Nigeria announced the doctor's death in PortHarcourt, the main oil industry terminal of Africa's largestcrude exporter. The doctor had treated a patient who evadedquarantine after coming into contact with Patrick Sawyer - aU.S. citizen who died in Lagos after flying in from Liberia lastmonth.

Health Ministry spokesman Dan Nwomeh wrote in his Twitterfeed that 70 people were now under surveillance in PortHarcourt, which is home to foreigners working for internationaloil companies.

A spokesman for leading operator Royal Dutch Shell said in London that the firm was "liaising with healthauthorities on the steps being taken to contain the disease".

Oil traders in Europe said insurance premiums for Nigeriancargoes had gone up slightly, but otherwise business wascontinuing as normal.

Analysts urged caution. "While major disruption to oilproduction appears unlikely, any further spread of Ebola ... islikely to cause serious operational challenges," said RoddyBarclay of the Control Risks consultancy.

According to new figures released on Thursday, Nigeria hasrecorded 17 cases, including six deaths, from Ebola, sinceSawyer collapsed upon arrival at Lagos airport in late July.

While Nigeria has yet to suffer any major economicdisruption, the International Monetary Fund said the smaller,poorer nations at the heart of the epidemic were being badlyhurt. "The Ebola outbreak is having an acute macroeconomic andsocial impact on three already fragile countries in WestAfrica," IMF spokesman Gerry Rice told reporters in Washington.

Rice said the IMF was assessing the impact and any extrafinancing needs with Guinea, Liberia and Sierra Leone.

AID EFFORT CHOKED OFF

The Lagos case contributed to the decision by a number ofairlines to halt services to Ebola-affected countries. AirFrance said on Wednesday it had suspended flights toSierra Leone on the advice of the Frenchgovernment.

Aylward said it was vital to restore commercial airlineroutes to the region to help transport aid workers and supplies,but in the meantime the WHO plan includes an "air bridge" to beoperated by the U.N.'s World Food Programme.

"We assume current airline limitations will stop within thenext couple of weeks. This is absolutely vital," he said. "Rightnow the aid effort risks being choked off."

West African health ministers meeting in Ghana on Thursdayechoed the WHO's concerns and called for the reopening ofborders and an end to flight bans. (Additional reporting by Kwasi Kpodo in Accra, Ben Hirschlerand Julia Payne in London, Anna Yukhananov in Washington andSharon Begley in New York; Writing by Joe Bavier; Editing byDaniel Flynn and David Stamp)

More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.